Saundra L. Pelletier is CEO at Evofem Biosciences, Inc. (EVFM). They have made 10 open-market trades across 2 companies since 2018, most recently 2022-12-31.
CIK 0001251371
7 open-market purchases totalling $416K since 2018, against 3 sales. Across 7 scored buys the stock is up 17.5% at ninety days, and 15.2 points ahead of the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 43% | 57% | 43% |
| Avg Move | -0.9% | +37.6% | +17.5% |
| Alpha | -0.1% | +37.1% | +15.2% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EVFM | BUY | 2022-05-27 | 2022-05-31 | $0.35 | $49K | -5.9% | +205.4% | +29.3% |
| EVFM | BUY | 2021-12-20 | 2021-12-20 | $0.38 | $51K | -9.0% | +18.2% | -5.4% |
| TCON | BUY | 2021-07-26 | 2021-07-27 | $3.82 | $25K | -3.2% | +1.6% | -5.3% |
| EVFM | BUY | 2021-06-10 | 2021-06-10 | $1.03 | $52K | +1.8% | -14.6% | -26.6% |
| EVFM | BUY | 2021-03-09 | 2021-03-09 | $2.28 | $206K | +3.9% | -31.8% | -60.1% |
| EVFM | SELL | 2020-09-08 | 2020-09-10 | $3.26 | $399K | -2.1% | +23.3% | -8.5% |
| TCON | BUY | 2020-06-11 | 2020-06-16 | $2.04 | $11K | -2.4% | -3.8% | +132.9% |
| EVFM | SELL · 10b5-1 | 2020-01-13 | 2020-01-15 | $6.00 | $20K | -14.8% | -8.1% | -12.0% |
| EVFM | SELL · 10b5-1 | 2020-01-02 | 2020-01-06 | $6.05 | $41K | +10.2% | -15.7% | -10.0% |
| EVFM | SELL | 2019-12-02 | 2019-12-04 | $7.30 | $146K | -10.8% | -14.0% | -7.7% |
| EVFM | SELL | 2019-11-21 | 2019-11-21 | $6.01 | $60K | +3.1% | -2.8% | +6.5% |
| EVFM | BUY | 2018-08-10 | 2018-08-13 | $2.11 | $21K | +8.3% | +88.0% | +57.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.